New bill could broaden medical marijuana eligibility in West Virginia
CLARKSBURG, W.Va. (WBOY) — A proposed amendment to West Virginia's medical cannabis law could broaden the number of 'serious medical conditions' eligible to be treated with medical marijuana.
House Bill 2765, which was introduced Friday morning, looks to change the definition of a 'serious medical condition' as it pertains to the West Virginia Medical Cannabis Act.
Currently, the definition of a 'serious medical condition' names 15 different medical conditions that qualify for treatment with medical marijuana. This amendment would remove those conditions and replace the definition to mean 'a medical condition that a medical doctor, in his or her professional judgment, would benefit from the use of cannabis.'
This would mean that, regardless of the condition, if a doctor believed medical cannabis would help treatment, it could qualify for medical marijuana treatment.
Bill to remove abortion exemptions for rape, incest introduced for second time in West Virginia legislative session
Delegate Mike Pushkin (D – Kanawha, 054) is the lead sponsor of the bill and is joined by four others, two of which are from north central West Virginia:
Anitra Hamilton (D – Monongalia, 081)
Evan Hansen (D – Monongalia, 079)
Sean Hornbuckle (D – Cabell, 025)
Hollis Lewis (D – Kanawha, 057)
You can read the full bill below or online; you can also track the progress of House Bill 2765 on the West Virginia Legislature website.
hb2765-intrDownload
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
ALS Walk raises over $100k
(WHTM) — Dozens came out to Hershey for the 2025 ALS Walk on Saturday. It was held at the Hershey Middle School on Homestead Road. The walk raises money to help fight the disease. Download the abc27 News+ app on your Roku, Amazon Fire TV Stick, and Apple TV devices Over $100,000 was collected. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Epoch Times
11 hours ago
- Epoch Times
Nasal, Baby Teething Swabs Recalled Nationwide Over Microbial Contamination Fears
New Jersey-based Church & Dwight Co., Inc. is recalling three nasal and baby teething swab products due to potential fungal contamination in the cotton swab components, the company said in a June 6 The recall is applicable to three products: Zicam Cold Remedy Nasal Swabs designed to tackle the common cold, Zicam Nasal AllClear Swabs used for cleansing, and Orajel Baby Teething Swabs aimed at soothing teething discomfort among toddlers and infants.
Yahoo
17 hours ago
- Yahoo
Why Oscar Health, Inc. (OSCR) Soared On Thursday
We recently published a list of . In this article, we are going to take a look at where Oscar Health, Inc. (NYSE:OSCR) stands against other best-performing stocks on Thursday. Oscar Health snapped a five-day losing streak on Thursday, jumping 10.6 percent to close at $15.65 apiece as investors resorted to bargain-hunting while waiting for more concrete developments on the Trump administration's Medicare Advantage review. Earlier this year, lawmakers passed a $5-trillion tax-and-spending package that shaves as much as $900 billion in Medicaid, which servers over 70 million low-income households. A close up of a patient and a healthcare professional engaging in conversation, showing the company's commitment to patient care. Now, Senate Republicans to broaden savings by looking for supposed inefficiencies in the Medicare program for senior citizens. In the first quarter of the year, Oscar Health, Inc. (NYSE:OSCR) registered a 55-percent increase in attributable net income of $275 million versus the $177 million registered in the same period last year. Revenues rose by 42 percent to $3.046 billion from $2.142 billion year-on-year. Overall, OSCR ranks 5th on our list of best-performing stocks on Thursday. While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data